Change over period: —
NSE · SURAKSHA
SURAKSHA
-2.4% from the 52-week high · +52.7% above the low
Suraksha Diagnostic Ltd operates a network of diagnostic centers providing medical testing and healthcare services. The company offers advanced lab services, preventive healthcare solutions, and timely reports to patients. It aims to improve healthcare accessibility across urban and semi-urban areas while maintaining high standards of quality and safety.
The short version. SURAKSHA reported revenue of ₹99 crore for Sep 2026, up 25.3% from a year earlier. Net profit was ₹15 crore (up 66.7% year on year). Return on equity was 13.2% in Mar 2026. Promoter holding was 49.1% in Sep 2026, up 0.32 points over 8 quarters.
1 · The price
How has the stock traded?
SURAKSHA trades 2.4% below its 52-week high and 52.7% above its 52-week low.
2 · The business
Is it growing?
Sep 2026 revenue of ₹99 cr.
Sep 2026 net profit of ₹15 cr.
3.8 pts higher than a year earlier.
Reported results · ₹ crore
Revenue and profit
Show the numbers
Quarterly
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 99 | 88 | 81 | 78 | 79 | 73 | 65 | 60 |
| Net profit | 15 | 13 | 6 | 8 | 9 | 9 | 7 | 6 |
| Net margin % | 15.2 | 14.8 | 7.7 | 9.7 | 11.4 | 12.9 | 11.4 | 10.1 |
| EPS (₹) | 2.88 | 2.5 | 1.21 | 1.44 | 1.73 | 1.8 | 1.42 | 1.15 |
Annual
| FY2026 | FY2025 | |
|---|---|---|
| Revenue | 310 | 252 |
| Net profit | 32 | 32 |
| Net margin % | 10.4 | 12.6 |
| EPS (₹) | 6.18 | 6.11 |
3 · The quality
How well does it turn capital into profit?
Return on equity was 13.2% in Mar 2026; debt to equity is 0.01.
Profitability · 2 years
Returns and margins
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Return on equity % | 13.2 | 15.1 |
| Return on capital % | 14.7 | 17.1 |
| EBITDA margin % | 31.4 | 33.2 |
| Net margin % | 10.3 | 12.4 |
Compound growth
Revenue vs profit
| 3 years | 5 years | |
|---|---|---|
| Revenue CAGR | — | — |
| Profit CAGR | — | — |
4 · The owners
Who holds it, and are they adding?
Up 0.32 pts over 8 quarters.
Down 1.42 pts over 8 quarters.
Up 1.12 pts over 8 quarters.
+2 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 48.78 | 48.78 | 48.88 | 48.98 | 49.0 | 49.1 | 49.1 | 49.1 | +0.32 |
| FII | 15.39 | 14.46 | 13.95 | 13.72 | 13.46 | 13.46 | 13.47 | 13.97 | -1.42 |
| DII | 20.44 | 22.05 | 22.37 | 21.98 | 22.57 | 23.14 | 23.23 | 21.56 | +1.12 |
| Public | 15.39 | 14.7 | 14.8 | 15.31 | 14.98 | 14.31 | 14.21 | 15.37 | -0.02 |
Mutual fund holdings · Oct 2026
10 schemes hold this stock
8 the month before.
- NIPPON INDIA PHARMA FUND1.36% of NAV
- ADITYA BIRLA SUN LIFE PHARMA & HEALTHCARE FUND0.97% of NAV
- JM Small Cap Fund0.83% of NAV
- JM Value Fund0.82% of NAV
- Kotak Small Cap Fund0.64% of NAV
- Bandhan Innovation Fund0.44% of NAV
- ADITYA BIRLA SUN LIFE ELSS TAX SAVER FUND0.39% of NAV
- Bandhan Balanced Advantage Fund0.17% of NAV
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for SURAKSHA are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Healthcare Services stocks
Quick answers
Common questions about SURAKSHA
What is the SURAKSHA share price?
SURAKSHA (SURAKSHA) last closed at ₹329.90, down 5.21% on the day. Its 52-week range is ₹227.95 to ₹356.45.
What is the market cap of SURAKSHA?
SURAKSHA has a market capitalisation of about ₹1,807 crore. Its price-to-earnings ratio is 43.5.
How are SURAKSHA's latest results?
SURAKSHA reported revenue of ₹99 crore for Sep 2026, up 25.3% from a year earlier. Net profit was ₹15 crore (up 66.7% year on year). Return on equity was 13.2% in Mar 2026. Promoter holding was 49.1% in Sep 2026, up 0.32 points over 8 quarters.
Who owns SURAKSHA?
As of Sep 2026, shareholding was: Promoter 49.1%, FII 13.97%, DII 21.56%, Public 15.37%.
How many mutual funds hold SURAKSHA?
10 mutual fund schemes held SURAKSHA in October 2026. That compares with 8 the month before.
Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.